STOCK TITAN
  1. Home
  2. DRREDDY

DRREDDY (DRREDDY) Stock Price, News & Analysis

DRREDDY
Published by Stock Titan Data refreshed

What Changed

Company Description

This page collects what Stock Titan holds for DRREDDY, including price data and latest news.

Stock Performance

Chart
$—
-
-
Last updated:
-
Performance 1 year
-
Market Cap
-
Shares outstanding

Latest News

View All
—

Dr. Reddy's Laboratories Announces the Launch of Lansoprazole DR Orally Disintegrating Tablets in the U.S. Market

—

Dr. Reddy's Laboratories announces the launch of Fluphenazine Hydrochloride Tablets, USP in the U.S. Market

—

Dr. Reddy's Laboratories Announces the Launch of Vigabatrin Tablets, USP in the U.S. Market

—

Dr. Reddy’s Q3 & 9M FY21 Financial Results

earnings
—

Dr. Reddy’s and GRA announces Avigan Pivotal Studies Update

—

Dr. Reddy’s Receives Approval to Conduct Phase 3 Clinical Trial for Sputnik V Vaccine in India

clinical trial
—

Sputnik V meets the primary endpoint of safety in the Phase 2 Clinical Trial in India

clinical trial
—

Dr. Reddy's Laboratories announces the launch of Febuxostat Tablets in the U.S. Market

—

Dr. Reddy's to Release Q3 FY 21 Results on January 29th, 2021

DRREDDY has 9 recent news articles. Key topics include earnings, clinical trial. View all DRREDDY news →

SEC Filings

View All

No SEC filings available for DRREDDY.